Disclosures for "Recovery After Acute Diesel Exhaust Inhalation Demonstrates Persistent Neuroinflammation and Sex-based Differences in Resolution of Neurotoxicity"
-
Miss Demetriou has nothing to disclose.
-
Miss Chen has nothing to disclose.
-
Dr. Shkirkova has nothing to disclose.
-
Dr. Zhang has nothing to disclose.
-
Dr. Lamorie-Foote has nothing to disclose.
-
Mr. Becerra has nothing to disclose.
-
Mr. Zhao has nothing to disclose.
-
Dr. Thorwald has nothing to disclose.
-
Dr. Godoy has nothing to disclose.
-
Wendy Mack has received personal compensation for serving as an employee of University of Southern California. Wendy Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Wendy Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wake Forest University. Wendy Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Virginia Commonwealth University. The institution of Wendy Mack has received research support from NIH.
-
Prof. Sioutas has nothing to disclose.
-
Prof. E Finch has stock in acumen pharmaceuticals. The institution of Prof. E Finch has received research support from University of Southern California, Leonard Davis School of Gerontology. The institution of Prof. E Finch has received research support from University of Southern California, Leonard Davis School of Gerontology.
-
Prof. Pike has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Holy Stone Healthcare . The institution of Prof. Pike has received research support from Cure Alzheimer Fund. The institution of Prof. Pike has received research support from NIH.
-
William Mack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Imperative Care. William Mack has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rebound Therapeutics. William Mack has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JNNP. William Mack has stock in Viseon. William Mack has stock in Q'apel. William Mack has stock in Borvo. William Mack has stock in Radical Catheters. William Mack has stock in Vastrax. William Mack has stock in Egret Therapeutics. William Mack has stock in Stream Biomedical. William Mack has stock in Sparten Micro. The institution of William Mack has received research support from NIH. William Mack has received personal compensation in the range of $50,000-$99,999 for serving as a investor with Truvic.